Key Takeaways
- • Goldman Sachs adjusted its price target on Ares Management to $139 from $137, maintaining a Buy rating on the alternative asset manager.
- • The consensus analyst rating across the Street remains "Buy" or "Overweight," with the mean price target from FactSet at $146.47 and from S&P Global at $146.89.
- • Ares Management trades near $142.32, positioning it slightly below consensus targets, with analyst price targets ranging from a low of $131.00 to a high of $210.00.
- • Recent competitive analyst moves include BofA Securities raising its target to $160 from $141 and Jefferies lowering its target to $124 from $136, reflecting divergent views on the firm's valuation.
- • Goldman Sachs previously removed Ares Management from its US Conviction List in June, signaling reduced conviction despite maintaining its Buy rating.
Summary
Goldman Sachs made a minor adjustment to its price target on Ares Management, raising it to $139 from $137 while maintaining a Buy rating on the alternative asset manager. The modest $2 upward revision reflects marginal confidence adjustments amid a complex analyst landscape for the NYSE-listed firm.
Ares Management commands broad institutional support, with consensus ratings of "Buy" or "Overweight" across major investment banks. According to FactSet data, the mean price target stands at $146.47, while S&P Global's survey of 18 analysts yields an average target of $146.89. This consensus sits approximately 3% above the current trading price of $142.32, suggesting modest upside potential from current levels. The broader analyst universe maintains significant price target dispersion, with high estimates reaching $210.00 and low estimates as far down as $131.00—a spread that underscores divergent views on the firm's growth trajectory and valuation multiples.
Recent analyst activity shows mixed momentum. Bank of America Securities raised its price target to $160 from $141, signaling increased confidence in the firm's prospects. Conversely, Jefferies cut its target to $124 from $136, reflecting a more cautious stance. These competing moves illustrate the tension in the investment community regarding Ares Management's near-term trajectory and valuation justification.
A notable development occurred in late June when Goldman Sachs removed Ares Management from its US Conviction List as part of a monthly portfolio update. This removal, despite the maintained Buy rating, suggests that while Goldman views the stock positively, conviction levels have diminished relative to other opportunities in the alternative asset management space. The distinction between a Buy rating and placement on a conviction list is material for hedge fund and institutional investors tracking high-conviction calls.
For alternative investment professionals evaluating Ares Management, the current positioning reflects cautious optimism with significant analyst disagreement on valuation. The stock trades near consensus targets but well below the highest analyst expectations, creating a risk-reward asymmetry that warrants individual portfolio consideration based on specific conviction levels and alternative manager exposure strategies.
Ares Management commands broad institutional support, with consensus ratings of "Buy" or "Overweight" across major investment banks. According to FactSet data, the mean price target stands at $146.47, while S&P Global's survey of 18 analysts yields an average target of $146.89. This consensus sits approximately 3% above the current trading price of $142.32, suggesting modest upside potential from current levels. The broader analyst universe maintains significant price target dispersion, with high estimates reaching $210.00 and low estimates as far down as $131.00—a spread that underscores divergent views on the firm's growth trajectory and valuation multiples.
Recent analyst activity shows mixed momentum. Bank of America Securities raised its price target to $160 from $141, signaling increased confidence in the firm's prospects. Conversely, Jefferies cut its target to $124 from $136, reflecting a more cautious stance. These competing moves illustrate the tension in the investment community regarding Ares Management's near-term trajectory and valuation justification.
A notable development occurred in late June when Goldman Sachs removed Ares Management from its US Conviction List as part of a monthly portfolio update. This removal, despite the maintained Buy rating, suggests that while Goldman views the stock positively, conviction levels have diminished relative to other opportunities in the alternative asset management space. The distinction between a Buy rating and placement on a conviction list is material for hedge fund and institutional investors tracking high-conviction calls.
For alternative investment professionals evaluating Ares Management, the current positioning reflects cautious optimism with significant analyst disagreement on valuation. The stock trades near consensus targets but well below the highest analyst expectations, creating a risk-reward asymmetry that warrants individual portfolio consideration based on specific conviction levels and alternative manager exposure strategies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.